Pharmacy researchers in Hong Kong have developed an AI-driven tool that predicts cardiovascular risks beyond genetics, monitoring near-real-time biological changes before diseases become apparent.
Read more here.
Automated radiomics-based artificial intelligence tools are being evaluated as decision-support systems that may assist radiologists in lesion detection and risk assessment while fitting into established prostate cancer diagnostic pathways.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us